Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Ono Pharmaceutical Co., Ltd.

News headline image
Ono Shares Replay Information for 44th Annual J.P. Morgan Healthcare Conference Presentation
From Ono Pharmaceutical Co., Ltd.
Via Business Wire
News headline image
Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Ono Pharmaceutical Co., Ltd.
Via Business Wire
News headline image
Ono Announces ONO-4578 (EP4 antagonist) in Combination with Opdivo and Chemotherapy Met the Primary Endpoint in a Phase 2 Clinical Trial in Patients with Certain Gastric Cancer
From Ono Pharmaceutical Co., Ltd.
Via Business Wire
News headline image
Ono Announces Encouraging Efficacy Signals of ONO-2808, a S1P5 Receptor Agonist, in an interim analysis of Ongoing Phase 2 Clinical Trial in Patients with Multiple System Atrophy
From Ono Pharmaceutical Co., Ltd.
Via Business Wire
News headline image
Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
From Ono Pharmaceutical Co., Ltd.
Via Business Wire
News headline image
ONO PHARMA Presents Positive Results From Pivotal Trial in U.S. Patients With Relapsed or Refractory PCNSL at 2025 ASCO Annual Meeting
From Ono Pharmaceutical Co., Ltd.
Via Business Wire
News headline image
Ono Pharma Announces an Oral Presentation on Phase 2 Data for Tirabrutinib and a Poster Session on ONO-4578 (EP4 Antagonist) at the American Society of Clinical Oncology (ASCO) Annual Meeting
From Ono Pharmaceutical Co., Ltd.
Via Business Wire
News headline image
Ono Commences Research Collaboration with Jorna Therapeutics to Generate Novel RNA Editing Therapeutics
From Ono Pharmaceutical Co., Ltd.
Via Business Wire
News headline image
Ono Enters into License Agreement with Ionis Pharmaceuticals for Sapablursen for the Treatment of Polycythemia Vera
From Ono Pharmaceutical Co., Ltd.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.